ArticleJournal of inflammation research2026
Identification of Immune-Related Genes in Predicting the Progression of Colitis-Associated Colorectal Cancer: An Integrated Bioinformatics and Experimental Validation Study.
Article in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Immune infiltration plays an important role in the pathogenesis of both ulcerative colitis (UC) and colorectal cancer (CRC). Our aim is to explore the significance of immune cell-related genes in colitis-associated colorectal cancer (CAC). Methods: Datasets related to UC and CRC were sourced from public databases. Key immune cell-related CAC genes (IC-CACs) were obtained by using WGCNA, differential expression and elastic net logistic regression analyses. Their diagnostic performance was assessed via ROC curves. Single-cell RNA sequencing (scRNA-seq) data were analyzed using the AUCell algorithm. Prognostic signatures were developed from differentially expressed genes between AUCell score-high and -low groups using Cox and LASSO regression. Moreover, the expressions of IC-CACGs were examined by RT-qPCR using clinical samples. Results: We obtained 13 key IC-CACGs correlated with neutrophils and dendritic cells. ROC curves revealed that key IC-CACGs had the good ability to distinguish UC or CRC patients from controls. scRNA-seq analysis revealed enrichment of interferon response, inflammation, and PI3K-Akt-mTOR signaling in AUCell scorehigh groups, while glycolysis and EMT were enriched in scorelow groups. A 20-gene prognostic signature was constructed and validated, with low-risk patients showing better overall survival. Key IC-CACGs correlated strongly with prognostic genes, and high-risk patients exhibited higher TIDE scores, suggesting poorer immunotherapy response. Conclusion: Our results provide the evidence for the promising role of immune cell-related genes in the development of CAC and new ideas for CAC prevention and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.